Amanote Research
Register
Sign In
182. Genetically Engineered Malignant Glioma-Specific T Cells Resistant to Glucocorticoids
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)37623-7
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2010
Authors
Unknown
Publisher
Elsevier BV
Related search
Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T Cells
Clinical Cancer Research
Cancer Research
Oncology
Treating Cancer With Genetically Engineered T Cells
Trends in Biotechnology
Bioengineering
Biotechnology
234. T Cells Genetically Modified to Express Chimeric Antigen Receptor Specific for EGFR for Glioma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Genetically Engineered T Cells Expressing a HER2-specific Chimeric Receptor Mediate Antigen-Specific Tumor Regression
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Extrathymic Generation of Tumor-Specific T Cells From Genetically Engineered Human Hematopoietic Stem Cells via Notch Signaling
Cancer Research
Cancer Research
Oncology
Application of Genetically Engineered Tumor-Specific Th1 Cells to Adoptive Tumor Immunotherapy
Annals of Cancer Research and Therapy
Cancer Research
Oncology
Pharmacology
Antitumor Activity From Antigen-Specific CD8 T Cells Generated in Vivo From Genetically Engineered Human Hematopoietic Stem Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor
Gastroenterology
Hepatology
Gastroenterology
Therapeutic Effect of Genetically Engineered Mesenchymal Stem Cells in Rat Experimental Leptomeningeal Glioma Model
Cancer Letters
Cancer Research
Oncology
